Oncology White Papers & Case Studies

1. SynteractHCR Full-Service CRO Brochure 3/4/2016

   SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

2. Research Solutions To Understand Clinical Therapy Market Landscapes 10/6/2015

   Covance was approached by a European client that was considering the acquisition of an early-stage ovarian cancer therapy product.

3. ECG Assessments During The Development Of Oncology Compounds 8/5/2015

   Assessment of ECGs during the development of oncology compounds is challenging. By THIJS van IERSEL, MD, Clinical Pharmacologist and Senior Director, Global Scientific Affairs, PRA Health Sciences; BORJE DARPO, MD, PhD, Chief Scientific Officer, iCardiac Technologies Inc.; GERD AROLD, MD, Senior Director, Global Scientific Affairs, PRA Health Science

4. Critical Success Factors For Clinical Trials Of Immune Checkpoint Inhibitors 7/20/2015

   Oncologists and their patients have had reason recently to be encouraged by the launch of immune checkpoint inhibitors (ICIs) for the treatment of several difficult-to-treat diseases, including metastatic melanoma and non-small cell lung cancer. These novel agents activate the human immune response against antigens expressed on tumor cells, and the science has generated excitement among physicians, patients, the media and researchers.

5. Taking The Guesswork Out Of Feasibility Assessment In Oncology Trials 7/20/2015

   The scientific progress being made in cancer research has never been more encouraging or more rewarding. Yet, virtually all oncology drug sponsors face an uphill battle in what one would expect to be the easiest part of the research process: recruiting patients for clinical trials. Despite the seriousness of the diagnosis—or perhaps because of it—only three percent of adult patients with cancer participate in clinical trials. As a result, under-enrollment is common.

6. Rare Diseases Clinical Trial Services 12/17/2014

   Clinical development involving rare diseases poses a unique set of medical, scientific, and operational challenges. 

7. Safety Expertise Leads To FDA Approval For Customer Compound 6/17/2013

   INC Research/inVentiv Health was providing a client with drug safety services for an oncology compound development.

8. Overcoming Clinical Challenges In Oncology With Metabolomics 4/10/2013

   Cancer continues to be a formidable disease with an overall success rate of bringing new drugs to market of only 5-8%.

9. Oncology Services Brochure 3/15/2012
   A leading western CRO in Russia, ClinStar offers invaluable experience to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise, as well as clinical teams that are therapeutically trained in oncology.